PROXIMITY EXTENSION
DEAD

Serial Number

97725094

Owner

Olink Proteomics AB

Attorney

Donna J. Bunton

Filing Date

Dec 20, 2022

Add to watchlist:

No watchlists yet
View on USPTO

PROXIMITY EXTENSION Trademark

Serial Number: 97725094

PROXIMITY EXTENSION is a trademark filed by Olink Proteomics AB on December 20, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Olink Proteomics AB (9 trademarks)

Salagatan 16F

Entity Type: 99

Trademark Details

Filing Date

December 20, 2022

Registration Date

Not Registered

Goods & Services

Scientific apparatus and instruments for use in science and research, namely, in analysis of the composition and content of samples of biological and non-biological origin; Scientific apparatus and instruments for use in analysis of concentration of analytes in samples of biological origin, wherein the analytes are biomarkers, namely, peptides, proteins and nucleic acid molecules and combinations thereof

Chemical preparations for medical purposes for measurement of analytes in samples of human and animal origin for diagnostic purposes, wherein the analytes are biomarkers, namely, peptides, proteins and nucleic acid molecules and combinations thereof; Chemical preparations for measurement of biomarker signatures in samples of human and animal origin for medical diagnostic purposes

Chemical compositions for use in scientific analysis of the composition and content of samples of biological and non-biological origin, other than for medical or veterinary purposes; Chemical compositions for use in scientific analysis, other than for medical or veterinary purposes, for use in measuring concentration of analytes in samples of biological origin, wherein the analytes are biomarkers, namely, peptides, proteins and nucleic acid molecules and combinations thereof

Medical analysis services for diagnostic purposes, namely, for understanding human and animal conditions and disease using analysis and measurement of analytes in samples of human and animal origin, wherein the analytes are biomarkers, namely, peptides, proteins and nucleic acid molecules and combinations thereof; Medical analysis services for diagnostic purposes, namely, for understanding human and animal conditions and disease using analysis and measurement of biomarker signatures in samples of human and animal origin

Medical apparatus and instruments for measurement of analytes in samples of human and animal origin for diagnostic purposes, wherein the analytes are biomarkers, namely, peptides, proteins and nucleic acid molecules and combinations thereof; Medical apparatus and instruments for measurement of biomarker signatures in samples of human and animal origin for diagnostic purposes

Scientific services, namely, scientific analysis in the field of analyzing the composition and content of samples of biological and non-biological origin; Scientific services, namely, scientific analysis in the field of analyzing the concentration of analytes in samples of biological origin, wherein the analytes are biomarkers, namely, peptides, proteins and nucleic acid molecules and combinations thereof

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Mar 12, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 12, 2025 ABN2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Nov 24, 2024 GNS2
INQUIRY TO SUSPENSION E-MAILED
Nov 24, 2024 GNSI
SUSPENSION INQUIRY WRITTEN
Nov 24, 2024 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 5, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 5, 2024 GNSL
SUSPENSION LETTER WRITTEN
Jan 5, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 21, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 21, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 21, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 21, 2023 GNRN
NON-FINAL ACTION E-MAILED
Sep 21, 2023 GNRT
NON-FINAL ACTION WRITTEN
Sep 21, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 21, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 17, 2023 NWOS
NEW APPLICATION ENTERED
Dec 23, 2022 NWAP